title: Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival.
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Jaspers
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Baron
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Sophie
authors.initials: S
authors.lastname: Servais
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Marie
authors.initials: M
authors.lastname: Lejeune
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Évelyne
authors.initials: É
authors.lastname: Willems
authors.affiliation: Department of Statistics, SIME, CHU of Liège, Liège, Belgium.
authors.forename: Laurence
authors.initials: L
authors.lastname: Seidel
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Kaoutar
authors.initials: K
authors.lastname: Hafraoui
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Christophe
authors.initials: C
authors.lastname: Bonnet
authors.affiliation: Division of Hematology, Department of Medicine, CHU of Liège and University of Liège, Liège, Belgium.
authors.forename: Yves
authors.initials: Y
authors.lastname: Beguin
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004921:Erythropoietin / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000150:complications / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009894:Opportunistic Infections / Q000150:complications / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016019:Survival Analysis; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D004921:Erythropoietin